Medical device company Viacyte has developed a device called PEC-Direct that can protect stem cells to be able to live inside the body, produce insulin as needed and possibly cure type 1 diabetes (T1D). Stem cells are placed into PEC-Direct and take three months to become functioning islet cells. Viacyte recently implanted the device into two…
Scientists at SymbioCellTech (SCT) have developed a technology called Neo Islets for possible type 1 diabetes (T1D) cure. It combines Mesenchymal Stem Cells (MSCs) with culture-expanded pancreatic islet cells to form three-dimensional cellular clusters. The scientists performed the technique in mice. All treated mice demonstrated normal blood glucose control without the need for anti-rejection drugs or encapsulation devices….